2019 - News Updates
-
Validation of New High Throughput, Low Cost HPV Test for Cervical Cancer Prevention
High-throughput, low cost genotyping assay, TypeSeq, detects cervical precancer and estimates HPV vaccination efficacy.
-
Risk for Treatment-related Leukemia after Chemotherapy for Childhood Cancer has Increased Over Last 45 years
Risk of therapy-related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML) after initial chemotherapy for childhood cancer has significantly increased between 1975 and 2015, according to a new analysis by Pragati Advani, Ph.D., and colleagues.
-
MGUS Immune Markers Predict Risk of Progression to Multiple Myeloma
Longitudinal prospective study links changes in monoclonal gammopathy of undetermined significance (MGUS) immune markers with progression to multiple myeloma.
-
Breastfeeding Associated with Lower Breast Cancer Risk in Women with Li-Fraumeni Syndrome
Breastfeeding for at least seven months was associated with 43 percent reduced risk of breast cancer in women with the cancer predisposition syndrome, Li-Fraumeni Syndrome (LFS).
-
NCI study finds long-term increased risk of cancer death following common treatment for hyperthyroidism
Radioactive iodine (RAI) treatment for hyperthyroidism is associated with increased risk of death from solid cancers, including breast cancer, new study finds.
-
Stewart Awarded Scientific Tenure by the NIH
In June 2019, Douglas Stewart, M.D., was awarded scientific tenure by the NIH and promoted to senior investigator in the Clinical Genetics Branch.
-
Mirabello Awarded Scientific Tenure by the NIH
In June 2019, Lisa Mirabello, Ph.D., M.S., was awarded scientific tenure by the NIH and promoted to senior investigator in the Clinical Genetics Branch.
-
Antibodies to HPV16 Measured in Blood up to 28 Years Prior to Oropharyngeal Cancer Diagnosis
Human papillomavirus-16-E6 antibodies can be detected in the blood of people with oropharyngeal cancer up to 28 years prior to diagnosis, according to new study by the National Cancer Institute and the International Agency for Research on Cancer.
-
The Unique Role of Staff Clinicians in DCEG Research
Staff clinicians operate at the intersection of clinical care and research on natural history studies of families with cancer predisposition syndromes.
-
Mille Receives Bernard Wheatley Award
In May 2019, Matthew Mille received the Bernard Wheatley Award for best submitted paper to the Journal of Radiological Protection.
-
Higher Risk Threshold Better for Selecting Ever-Smokers for Lung Cancer Screening
Researchers determined a higher risk threshold for selecting ever-smokers for screening with low-dose CT could lower the ratio of individuals screened to prevent one lung cancer death, improving on US Preventive Services Task Force guidelines.
-
2019 Spring Town Hall Meeting
The spring town hall meeting was held in May 2019 to talk about recent scientific achievements and new and ongoing research efforts, and to recognize accomplishments and contributions of staff.
-
2019 Winners Announced for DCEG Informatics Tool Challenge
In May, Stephen Chanock announced four winners of the 2019 DCEG Informatics Tool Challenge, a competitive funding program that supports innovative approaches to enhance epidemiological methods, data collection, and analysis using modern technology and informatics.
-
Study shows incidence rates of aggressive subtypes of uterine cancer rising
New study shows that U.S. incidence rates for aggressive subtypes of uterine cancer rose rapidly among women age 30 to 79 from 2000 to 2015. Study also reveals racial disparities for these subtypes.
-
Future of Low-Dose Radiation Research in the US: 2019 Gilbert W. Beebe Symposium
The 2019 Gilbert W. Beebe Symposium focused on the future of low-dose radiation research and the need for a long-term strategy to guide low-dose radiation research in the United States.
-
DCEG Fellows Present at the 2019 NIH Postbac Poster Day
Eight postbaccalaureate fellows in DCEG presented at the May 2019 NIH Postbac Poster Day, sponsored by the NIH Office of Intramural Training and Education.
-
Medical Research Scholar Dalal Meets NCI Director Sharpless: NIH Catalyst Article
Medical Research Scholar (MRSP) Nicole Dalal meets former resident of her NIH Campus room, Ned Sharpless. Article by NIH Catalyst writer.
-
Dual-Staining Outperforms Cytology for Follow-up of HPV-positive Women in Cervical Cancer Screening Programs
Dual staining for p16/Ki-67 outperformed cytology in detecting precancer among HPV-positive women while referring fewer women to secondary screening, visual inspection of the cervix with magnification, known as colposcopy.
-
Longer Intervals Between Lung Cancer Screens Could Reduce False-Positives for Low-Risk Patients
A personalized approach for choosing how long to wait between lung cancer screenings could be an efficient way to reduce false-positives and other harms.